Podcast: Beyond Wearables--Profusa CEO Discusses Novel Tiny Injectable Biosensor For Long-Term Monitoring
In this podcast interview with Medtech Insight, Profusa Inc. Chairman and CEO Ben Hwang discusses the company's long-term biochemical monitoring platform, the first application for its tiny injectable biosensor, and what's next for the company.
You may also be interested in...
Digital Health company Profusa raised more than $45m in a series C financing round. The company plans to use the proceeds to bring its tiny CE-marked injectable biosensors, used to monitor tissue oxygenation in patients with peripheral artery disease, to key opinion leaders and clinicians in Europe.
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.